FXYD5/Dysadherin Antibody (Centrose patent anti-dysadherin) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28555G
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry, Functional
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Recombinant Monoclonal Human IgG1 Clone # Centrose patent anti-dysadherin
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary
Immunogen
Dysadherin
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Applications
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FXYD5/Dysadherin
Long Name
FXYD Domain-containing Ion Transport Regulator 5
Alternate Names
DYSAD, Dysadherin, EF-8, IWU1, KCT1, OIT2, PRO6241, RIC
Gene Symbol
FXYD5
Additional FXYD5/Dysadherin Products
Product Specific Notices
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...